Oncode Institute researcher Maximilian Madern has received the 2026 International Birnstiel Award for Doctoral Research in Molecular Life Sciences, recognising his doctoral research in the group of Oncode Investigator Marvin Tanenbaum at the Hubrecht Institute.

Two Synergy Projects look at how immune cells recognise tumour cells and how nearby cells respond to cell death, exploring processes that can influence cancer and treatment.

Two Synergy Projects explore processes that can shape how cancer cells change. Researchers are investigating the role of cell metabolism in genome stability and developing a new way to study DNA repair after chemotherapy.

Are you a freelance communications professional with a strong interest in science? Oncode Institute is looking for a Science Communications & Content Officer for a six-month freelance assignment, 24–28 hours per week.

New company builds on first-in-human clinical proof-of-principle and is developing a next-generation, multi-target TEIPP vaccine for immunotherapy-resistant cancers

Two collaborative projects explore how the environment around cancer cells can influence the development of metastases, from the role of obesity in the liver to interactions between colorectal cancer cells and immune cells in the peritoneal cavity.

Oncode researcher Agustin Enciso-Martinez has received a KWF Young Investigator Grant to investigate whether signals found in the blood could help detect pancreatic cancer earlier and provide earlier insight into treatment response.

As part of the Inside the Synergy Projects 2026 series, this edition highlights two collaborative projects that aim to improve how cancer is detected. From helping surgeons distinguish tumour tissue more accurately to revealing the earliest changes that lead to hereditary breast cancer, both collaborations seek to support better decisions throughout the patient journey.

Prof. dr. Henk Verheul, Chair of Oncode’s Clinical Advisory Board, reflects on the role of the Clinical Proof-of-Concept programme in helping researchers validate promising cancer discoveries in patients earlier and with a clearer view of clinical need.

Two collaborative projects supported through the Oncode Synergy Projects 2026 programme are exploring why some immune cells are exceptionally effective at fighting cancer while others lose their ability to respond. Together, they could help shape the next generation of cancer immunotherapies.

How can patients play a meaningful role in fundamental cancer research? Researchers and patient representatives reflect on the value of collaboration and why it matters.

Cancer research often takes place behind closed laboratory doors, in images, models and experiments that rarely reach the public. With Tiny Revelations, Professor Anne Rios wants to change that.

Oncode researcher Megan Farrell has received a Veni grant to study how signals from surrounding tissue affect immune cell activity.

Evaluation confirms that Oncode Institute is a proven infrastructure that connects fundamental cancer research with value for patients, healthcare, science and the economy.